English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Strontium-modification of porous scaffolds from mineralized collagen for potential use in bone defect therapy

MPS-Authors
/persons/resource/persons126855

Simon,  Paul
Paul Simon, Chemical Metal Science, Max Planck Institute for Chemical Physics of Solids, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Quade, M., Schumacher, M., Bernhardt, A., Lode, A., Kampschulte, M., Voss, A., et al. (2018). Strontium-modification of porous scaffolds from mineralized collagen for potential use in bone defect therapy. Materials Science & Engineering C, 84, 159-167. doi:10.1016/j.msec.2017.11.038.


Cite as: http://hdl.handle.net/21.11116/0000-0001-2E99-0
Abstract
The present study describes the development and characterization of strontium(II)-modified biomimetic scaffolds based on mineralized collagen type I as potential biomaterial for the local treatment of defects in systemically impaired (e.g. osteoporotic) bone. In contrast to already described collagen/hydroxyapatite nanocomposites calcium was substituted with strontium to the extent of 25, 50, 75 and 100 mol% by substituting the CaCl2-stock solution (0.1 M) with SrCl2 (0.1 M) during the scaffold synthesis. Simultaneous fibrillation and mineralization of collagen led to the formation of collagen-mineral nanocomposites with mineral phases shifting from nanocrystalline hydroxyapatite (Sr0) over poorly crystalline Sr-rich phases towards a mixed mineral phase (Sr100), consisting of an amorphous strontium phosphate (identified as Collin's salt, Sr6H3(PO4)5 ∗ 2 H2O, CS) and highly crystalline strontium hydroxyapatite (Sr5(PO4)3OH, SrHA). The formed mineral phases were characterized by transmission electron microscopy (TEM) and RAMAN spectroscopy. All collagen/mineral nanocomposites with graded strontium content were processed to scaffolds exhibiting an interconnected porosity suitable for homogenous cell seeding in vitro. Strontium ions (Sr2 +) were released in a sustained manner from the modified scaffolds, with a clear correlation between the released Sr2 + concentration and the degree of Sr-substitution. The accumulated specific Sr2 + release over the course of 28 days reached 141.2 μg (~ 27 μg mg− 1) from Sr50 and 266.1 μg (~ 35 μg mg− 1) from Sr100, respectively. Under cell culture conditions this led to maximum Sr2 + concentrations of 0.41 mM (Sr50) and 0.73 mM (Sr100) measured on day 1, which declined to 0.08 mM and 0.16 mM, respectively, at day 28. Since Sr2 + concentrations in this range are known to have an osteo-anabolic effect, these scaffolds are promising biomaterials for the clinical treatment of defects in systemically impaired bone.